Physician profile
Maha Zikra
NPI 1366425654
$26,059.29
in general payments reported to CMS, 2019-2025
62 companies · $5,526 in 2025
The $5,526 reported for 2025 was more than what 88% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,046 · 2020: $1,733 · 2021: $2,722 · 2022: $3,156 · 2023: $2,411 · 2024: $7,466 · 2025: $5,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,720 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,627 · Education: $56.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,719.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,626.57 |
| Education | $56.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicure Pharma INC. | $7,642.22 | 2022-2025 | Zypitamag |
| Lilly USA, LLC | $1,886.52 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $1,807.98 | 2019-2025 | Synthroid, Creon |
| Novo Nordisk INC | $1,681.22 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,461.15 | 2019-2025 | Jardiance, Synjardy |
| Sanofi-Aventis U.S. LLC | $1,231.40 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $890.82 | 2019-2023 | Farxiga |
| Xeris Pharmaceuticals, INC. | $846.12 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Vivus LLC | $810.79 | 2020-2025 | Pancreaze |
| Bayer Healthcare Pharmaceuticals INC. | $771.37 | 2022-2025 | |
| Amgen INC. | $504.18 | 2019-2025 | Tepezza, Repatha, Repatha |
| Esperion Therapeutics, INC. | $497.28 | 2020-2025 | Nexletol |
| Amneal Pharmaceuticals LLC | $487.85 | 2019-2025 | Unithroid |
| Janssen Pharmaceuticals, INC | $445.31 | 2019-2020 | |
| Radius Health, INC. | $385.79 | 2019-2024 | Tymlos |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $323.57 | 2020-2025 | Freestyle Libre |
| Recordati_rare_diseases_inc. | $317.21 | 2022-2025 | Isturisa, Signifor Lar |
| Antares Pharma, INC. | $299.65 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Medtronic, INC. | $266.73 | 2021-2025 | Minimed 780g, Intellis Adaptivestim, Inceptiv |
| Merck Sharp & Dohme LLC | $237.77 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $211.38 | 2020-2021 | |
| Astellas Pharma US INC | $208.10 | 2024-2025 | Veozah |
| Mannkind Corporation | $193.60 | 2019-2023 | Afrezza |
| Dexcom, INC. | $187.47 | 2021-2024 | Dexcom G6 Transmitter |
| Ascendis Pharma Endocrinology INC | $177.16 | 2023-2025 | Yorvipath |
| Insulet Corporation | $144.70 | 2021-2025 | Omnipod |
| Ibsa Pharma INC. | $138.96 | 2020-2022 | |
| Kyowa Kirin, INC. | $137.21 | 2022-2025 | |
| Medtronic USA, INC. | $132.86 | 2019 | |
| Allergan, INC. | $131.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $129.82 | 2022-2025 | |
| Gilead Sciences, INC. | $113.28 | 2022 | |
| Amphastar Pharmaceuticals, INC. | $111.02 | 2024-2025 | |
| Tandem Diabetes Care, INC. | $86.81 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Neurocrine Biosciences, INC. | $85.66 | 2025 | |
| Corcept Therapeutics | $84.47 | 2020-2025 | Korlym |
| Clarus Therapeutics INC. | $74.85 | 2021 | |
| Medtronic Minimed, INC. | $66.62 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $59.39 | 2025 | Zenpep |
| Amarin Pharma, INC. | $59.06 | 2019-2022 | |
| Madrigal Pharmaceuticals | $54.60 | 2025 | Rezdiffra |
| Shire North American Group INC | $54.22 | 2019 | |
| Sequel Med Tech, LLC | $51.83 | 2025 | Twiist |
| Abiomed | $48.11 | 2024-2025 | Impella |
| Cequr Corporation | $46.17 | 2021-2025 | Cequr Simplicity |
| Horizon Therapeutics Plc | $45.40 | 2022-2023 | Tepezza |
| Ascensia Diabetes Care US INC. | $41.50 | 2023 | |
| Pfizer INC. | $41.14 | 2023-2024 | |
| Grt US Holding, INC. | $38.33 | 2021-2022 | |
| Embecta Corp. | $34.24 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Rhythm Pharmaceuticals, INC. | $29.50 | 2025 | Imcivree |
| Nestle Healthcare Nutrition INC. | $29.45 | 2021-2023 | |
| Companion Medical, INC. | $24.75 | 2020 | |
| Amryt Pharma Holdings LTD | $24.55 | 2023 | Mycapssa |
| Eusa Pharma (US) LLC | $24.54 | 2022 | |
| Organogenesis INC. | $23.96 | 2023 | Puraply |
| Kvk-Tech, INC. | $23.79 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.29 | 2021 | |
| Tolmar, INC. | $20.87 | 2025 | Jatenzo |
| Intra-Sana Laboratories | $18.37 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Verity Pharmaceuticals INC. | $16.47 | 2025 | Tlando |
| Acerus Pharmaceuticals Corporation | $16.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maha Zikra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.